Business Context and Reporting Period
Company: LiveWire Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 23, 2026 (Event Date); July 29, 2026 (Signature Date)
Context: The Company is an emerging growth company incorporated in Delaware. This filing addresses a regulatory notice regarding the continued listing of its Common Stock on the New York Stock Exchange (NYSE).
Key Financial Metrics
This filing does not contain specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on regulatory compliance status regarding share price.
Material Changes
- Delisting Notice: On July 23, 2026, the Company received notice from the NYSE that it failed to meet the continued listing standard under Section 802.01C of the Listed Company Manual.
- Trigger Event: The average closing price of the Company's Common Stock was less than $1.00 per share over a consecutive 30 trading-day period ending July 22, 2026.
- Current Status: The notice has no immediate impact on the listing of the Common Stock, provided the Company complies with other listing requirements.
Guidance, Outlook, and Risks
- Cure Period: The Company has a six-month period from the receipt of the notice to regain compliance.
- Compliance Criteria: To cure the deficiency, the Common Stock must have a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of any calendar month within the cure period.
- Consequences of Failure: If compliance is not achieved within the six-month window, the NYSE will initiate procedures to suspend and delist the Common Stock.
- Management Intent: The Company intends to notify the NYSE of its intent to regain compliance within 10 business days of receipt.
- Risks: Forward-looking statements highlight risks related to the ability to maintain the listing, remain in compliance with term loan covenants, and procure additional financing on favorable terms.
Investor Verification Checklist
- Verify the current trading price and 30-day average of LiveWire Group, Inc. (LVWR) stock to assess the likelihood of meeting the $1.00 threshold.
- Monitor the Company's next 10 business days for the formal notification of intent to cure the deficiency to the NYSE.
- Review the Company's term loan agreements to understand potential default triggers if the stock price remains depressed.
- Check for any upcoming shareholder meetings where actions requiring approval (e.g., reverse stock split) might be proposed to cure the price condition.
- Confirm that the Company's business operations and SEC reporting obligations remain unaffected by the notice.